As stated at the beginning of this chapter, studies on the role of HIF1α and HIF2α in leukemia failed to produce universal consent, especially in AML and CLL where contrasting evidence has been reported (Table 2). The gene discussed is EPAS1; the disease is acute myeloid leukemia.